NCT00004904View on ClinicalTrials.gov

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

July 31, 2000

Study Completion Date

July 31, 2000

Conditions
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionSmall Intestine Cancer
Interventions
BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

filgrastim

DRUG

cladribine

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

methylprednisolone

DRUG

tacrolimus

PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (1)

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER